• Gene Therapy B-VEC Is Safe, Leads to Sustained Wound Healing in RDEB Patients, Phase 1/2 Trial Shows
  • EB-101 Cell Therapy Safely Heals Wounds in Adults with RDEB, Early Trial Results Show
  • With the End of Summer, I’m Starting A New Phase of My Life
  • Serlopitant May Reduce Itching in EB, But More Research Is Needed
  • New Guidelines for Foot Care in EB Stress Use of Podiatrists, Proper Footwear
  • FDA Halts Phase 3 Trial of Abeona’s EB-101 for RDEB Due to Transport Concerns
  • NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC
  • New Gene Editing Technique Shown to Correct COL7A1 Gene in RDEB Cells
  • DAAC Dressing Closes EB Wounds Faster Than Standard Saline-Antibiotic One, Study Says
  • Cell Therapy for RDEB Needs Collagen VII Repair in Two Types Skin Cells to Achieve Stability, Study Finds
  • ‘Disorder’ Film Festival Offers Look at Siblings Touched by Rare Diseases
  • First Patient Dosed in Phase 2 Trial of RGN-137 Achieves Complete Wound Healing, RegeneRx Announces